Industry

MedTech Start-Up Secures $8.1M in Series B3 Funding and Fills Multiple Positions to Support Organizational Growth DENVER–(BUSINESS WIRE)–Xtremity, a premium medical device brand that develops advanced prosthetic socket technology, today announced closing of a Series B3 financing round, totaling $8.1 million with strong insider participation and the addition of several prominent new investors. The cash … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Fragile X Syndrome – Pipeline Insight, 2022” clinical trials has been added to ResearchAndMarkets.com’s offering. The report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Fragile X Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product … [Read more…]

STONY BROOK, N.Y.–(BUSINESS WIRE)–$APDN #LinearDNA—Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based DNA technologies, announced today that it received its largest single purchase order for LinearDNA™ valued above the mid-six-figures. The order was placed under a long-standing supply agreement for the bulk manufacture of LinearDNA for a global manufacturer of in … [Read more…]

PITTSBURGH–(BUSINESS WIRE)–#healthcare–Plexision, a biotechnology company, which provides personalized diagnostic testing services for organ transplant patients has completed development of a six-hour blood test to predict organ transplant rejection – PlexAPR™. When combined with other clinical and laboratory information, rapid rejection-risk assessment can allow caregivers to intervene early, while arranging confirmatory biopsies, or during lifelong surveillance … [Read more…]

DOVER, Del.–(BUSINESS WIRE)–Mana Capital Acquisition Corp. (“Mana Capital”) (Nasdaq: MAAQU; MAAQ; MAAQW; MAAQR), a publicly traded special purpose acquisition company, today announced that its registration statement on Form S-4, relating to the previously announced business combination between Mana Capital and Cardio Diagnostics, Inc. (“Cardio”), a pioneering precision cardiovascular testing company, has been declared effective by … [Read more…]

ROCKVILLE, Md.–(BUSINESS WIRE)–#PowerofUnite–Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of LAMP-mediated nucleic acid-based immunotherapy announced today that it will present at the Vaccines Summit 2022 at the Sheraton Reston Hotel in Reston, VA on October 11-13. Associate Director, Vaccine Discovery, Wei Shen, Ph.D., will present a talk entitled, “Nucleic Acid-Based … [Read more…]

New technology provides accessible telemedicine, ensuring optimal outcomes and greater collaboration across the care continuum MISSISSAUGA, Ontario–(BUSINESS WIRE)–PointClickCare Technologies, a leading healthcare technology platform enabling meaningful collaboration and access to real‐time insights, today announced the launch of its Virtual Health offering – an integrated telemedicine solution to the Skilled Nursing Facilities (SNF) market. With the … [Read more…]

Clinical Expertise and Advanced Therapies Offer Patients Additional Care Resources in New Setting NORCROSS, Ga.–(BUSINESS WIRE)–#SoleoHealthVirtisHealth—Virtis Health, a national healthcare provider dedicated to therapeutic and diagnostic services for patients with complex conditions requiring specialty infusible and injectable medications, announced today its unveiling of an ambulatory infusion center (AIC) in the Atlanta area. Virtis Health Atlanta … [Read more…]

Rating agency notes market leadership in hospital professional liability and strong financials ALAMO, Calif.–(BUSINESS WIRE)–BETA Healthcare Group (BETA), the largest professional liability insurer of hospitals on the West Coast and provider of a host of liability and workers’ compensation coverages for healthcare organizations, has maintained its “A” (Excellent) rating with a “Stable” outlook from A.M. … [Read more…]

Total revenue of $89 to $90 million Total revenue growth of 42% to 43%, including organic revenue growth of 51% to 53% Full-year 2022 total revenue growth now expected to approximate 40% CARLSBAD, Calif.–(BUSINESS WIRE)–Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today select … [Read more…]